Morphle Labs has raised $5 million in Series A funding from Inflexor Ventures to expand globally and scale manufacturing of its robotic cancer-diagnostics systems. The Bengaluru startup builds automation tools such as RoboTome and MorphoLens to speed up and digitise tissue analysis. The investment will support regulatory approvals, hiring, and further innovation in physical AI for pathology.